Validation of Age-adjusted Shock indices for Predicting In-hospital outcomes in percutaneously REvascularized

Bryan Jacob Koithara1, Ravi Kalra2, Shashikala Sangle1

  • 1Department of General Medicine, Bharati Vidyapeeth (Deemed to be University) Medical College and Hospital, Pune-Satara Road, Dhankawadi, Pune, Maharashtra, 411043, India.

Indian Heart Journal
|October 12, 2025
PubMed

Insights

The Age-Shock Index (Age-SI) and Age-Modified Shock Index (Age-MSI) effectively predict major adverse cardiovascular events and mortality in ST-elevation myocardial infarction patients post-PCI, offering bedside risk stratification alternatives.

Area of Science:

  • Cardiology
  • Clinical Research
  • Medical Informatics

Background:

  • ST-elevation myocardial infarction (STEMI) requires prompt revascularization.
  • Accurate prediction of in-hospital outcomes is crucial for patient management.
  • Existing risk scores like GRACE may have limitations in certain populations.

Purpose of the Study:

  • To prospectively validate the Age-Shock Index (Age-SI) and Age-Modified Shock Index (Age-MSI) in Indian STEMI patients.
  • To compare the predictive performance of Age-SI and Age-MSI against the GRACE score for in-hospital MACE and mortality.
  • To assess the utility of Age-SI and Age-MSI for bedside risk stratification post-percutaneous coronary intervention (PCI).

Main Methods:

  • Prospective evaluation of 236 STEMI patients undergoing PCI.
  • Calculation and analysis of Age-SI, Age-MSI, and GRACE scores.
  • Determination of optimal cut-off values for predicting major adverse cardiovascular events (MACE) and all-cause mortality.

Main Results:

  • Age-SI and Age-MSI demonstrated significant predictive capabilities for both MACE and all-cause mortality.
  • Optimal Age-SI cut-offs showed sensitivities/specificities of 76.7%/67% for MACE and 82.4%/83% for mortality.
  • Optimal Age-MSI cut-offs showed sensitivities/specificities of 85%/56.2% for MACE and 77%/89% for mortality.
  • GRACE score (≥127.5) showed sensitivities/specificities of 60%/81.9% for MACE and 94%/76.7% for mortality.

Conclusions:

  • Age-SI and Age-MSI are valuable, simple tools for bedside risk stratification in Indian STEMI patients post-PCI.
  • These indices offer a practical alternative to traditional risk scores for predicting in-hospital adverse events.
  • Further validation in diverse populations may enhance their clinical applicability.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
804
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
213
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
219